NON-SMALL CELL LUNG CANCER

This adverse event was reported 4795 times

These drugs are most commonly taken by patients reporting NON-SMALL CELL LUNG CANCER:

# Drug Count
0 CARBOPLATIN 699
1 SOTORASIB 520
2 NIVOLUMAB 441
3 PEMETREXED DISODIUM 428
4 BRIGATINIB 396
5 PACLITAXEL 394
6 PEMETREXED 357
7 IPILIMUMAB 326
8 PACLITAXEL (AIBUMIN-BOUND) 310
9 CRIZOTINIB 287
See all common drugs associated with NON-SMALL CELL LUNG CANCER

NON-SMALL CELL LUNG CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SOTORASIB 520 0.1499
1 BRIGATINIB 396 0.1083
2 CERITINIB 130 0.0545
3 CAPMATINIB 95 0.0402
4 AMIVANTAMAB-VMJW 118 0.0330
5 CRIZOTINIB 287 0.0225
6 PEMETREXED DISODIUM 428 0.0109
7 ERLOTINIB HYDROCHLORIDE 135 0.0108
8 AFATINIB 66 0.0100
9 IPILIMUMAB 326 0.0074
See all drugs enriched for association with NON-SMALL CELL LUNG CANCER